BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.84
Delayed Data
As of Oct 30
 +0.11 / +2.95%
Today’s Change
1.38
Today|||52-Week Range
6.29
+11.30%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 13.00 and a low estimate of 4.50. The median estimate represents a +95.31% increase from the last price of 3.84.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$3.6M
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.25%
 
 
 
 
 
 
Growthannually 0.85%
 
 
 
 
 
 

Sales

Growthquarterly 25.55%
 
 
 
 
 
 
Growthannually -31.79%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.